PharmAsia News Notable Notes: WuXi Confronts Chinese Macro Challenges
This article was originally published in PharmAsia News
Executive Summary
WuXi Pharma has systems in place to soften the impact of cost inflation issues expected to impact the Chinese pharma industry, according to Oppenheimer analyst Charles Rhyee